Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532]
Saved in:
| Main Authors: | Tao Lin, Xusheng Tang, Wanli Yang, Hainan Yang, Zhaoming Zhou, Zhijie Chen, Yongqin Zeng, Weiping Hong, Minting Ye, Linbo Cai, Da Liu, Minying Li, Lei Wen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Heliyon |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025016305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker
by: Meejeong Kim, et al.
Published: (2025-04-01) -
Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome
by: Mingyuan Du, et al.
Published: (2024-12-01) -
Differences in Gender and Overall Survival for Temperature-Sensitive TP53 Mutations in Gastroesophageal Cancer
by: Danial H. Shaikh, et al.
Published: (2024-11-01) -
Prognostic factors influencing overall survival in stage IV EGFR-mutant NSCLC patients treated with EGFR-TKIs
by: Linwu Kuang, et al.
Published: (2025-03-01) -
Corrigendum to “Effects during the cathode polarization of porous silicon” [Heliyon Volume 10, Issue 15, August 2024, Article e34675]
by: V. Yakovtseva, et al.
Published: (2025-03-01)